PALI Historical PE Ratio image   This PALI PE ratio history page last updated 8/29/2022
PALI PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/15/2022
0.23-0.120.780.3
Q1 2022
5/13/2022
0.51-0.260.153.4
Q4 2021
3/17/2022
1.000.74-0.38NA
Q3 2021
11/15/2021
2.690.42NANA
Q2 2021
8/24/2021
2.60-0.75NANA
Q1 2021
5/14/2021
3.76-0.79NANA
PALI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/15/2022
0.23-0.12-0.48NA
Q1 2022
5/13/2022
0.51-0.26-1.04NA
Q4 2021
3/17/2022
1.000.742.960.3
Q3 2021
11/15/2021
2.690.421.681.6
Q2 2021
8/24/2021
2.60-0.75-3.00NA
Q1 2021
5/14/2021
3.76-0.79-3.16NA
Quotes delayed 20 minutes

Email EnvelopeFree PALI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Palisade Bio (PALI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PASG PE Ratio History
PAVM PE Ratio History
PBH PE Ratio History
PBLA PE Ratio History
PBYI PE Ratio History
PCRX PE Ratio History
PCSA PE Ratio History
PCVX PE Ratio History
PDCO PE Ratio History
PDEX PE Ratio History
On this page we presented the PALI PE Ratio History information for Palisade Bio' stock. The average PALI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PALI PE ratio history based on this TTM earnings result method is 1.8. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PALI PE ratio history result, against the recent PE: when this page was posted on 8/26/2022, the most recent closing price for PALI had been 0.18, and the most recent quarterly earnings result, annualized, was 2.96. Meanwhile, the most recent TTM earnings summed to 0.78. From these numbers, we calculate the recent PALI PE on 8/26/2022 based on annualized quarterly EPS was 0.1. Based on PALI's history, that recent PE is low relative to the historical average, with the recent PE 90.0% lower than the historical average PE across our data set for Palisade Bio. Looking at the recent PALI PE on 8/26/2022 based on TTM EPS, we calculate the ratio at 0.2. Based on PALI's history, that recent PE is low relative to the historical average, with the recent PE 88.9% lower than the average PE across our Palisade Bio data set with TTM EPS used in the calculation at each period.

Another interesting PALI PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for PALI, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for PALI, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.26, -0.12, 0.42, and 0.74. We then toss out the highest and lowest result, and then take the average of those two middle numbers — -0.12 and 0.42 — which gives us the median of 0.15. Basically the way to think about this 0.15 number is this: for the trailing four earnings reports, 0.15 marks the "middle ground" number where PALI has reported a value higher than 0.15 half the time, and has reported a value lower than 0.15 half the time. Annualizing that median value then gets us to 0.6/share, which we use as the denominator in our next PE calculation. With 0.18 as the numerator (as of 8/26/2022), the calculation is then 0.18 / 0.6 = 0.3 as the PALI PE ratio as of 8/26/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on PALI or any other given stock, valuation analysis for PALI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Palisade Bio PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for PALI. Thanks for visiting, and the next time you need to research PALI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: LABD Videos, NVIV market cap history, Institutional Holders of RYE.

 

PALI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.